Ethosuximide specifically antagonizes the effect of pentylenetetrazol in the rat entorhinal cortex

Epilepsy Research

Volumn 25, Issue 2, 1996, Pages 69-77

  Stringer, Janet L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antiepileptic drug; Dentate gyrus; Entorhinal cortex; Ethosuximide; Pentylenetetrazol; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; EPILEPSY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030272649     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-1211(96)00068-X     Document Type: Article

References (27)

1. [1] Ashton, D., Willems, R., De Prins, E. and Wauquier, A., Field-potential assay of antiepileptic drugs in the hippocampal slice, Epilepsia, 29 (1988) 321-329.
2. [2] Coulter, D.A., Huguenard, J.R. and Prince, D.A., Specific petit ma1 anticonvulsants reduce calcium currents in thalamic neurons, Neurosci. Lett., 98 (1989) 74-78.
3. 2+ medium, Brain Res., 631 (1993) 137-142.
4. [4] De Deyn, P.P. and Macdonald, R.L., Effects of antiepileptic drugs on GABA responses and on reduction of GABA responses by PTZ and DMCM on mouse neurons in cell culture, Epilepsia, 30 (1989) 17-25.
5. [5] Joy, R.M. and Albertson, T.E., Convulsant-induced changes in perforant path-dentate gyrus excitability in urethane anesthetized rats, J. Pharmacol. Exp. Ther., 246 (1988) 887-895.
6. [6] Kostyuk, P.G., Molokanova, E.A., Pronchuk, N.F., Savchenko, A.N. and Verkhratsky, A.N., Different action of ethosuximide on low- and high-threshold calcium currents in rat sensory neurons, Neuroscience, 51 (1992) 755-758.
7. [7] Löscher, W., Honack, D., Fassbender, C.P. and Nolting, B., The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazol seizure models, Epilepsy Res., 8 (1991) 171-189.
8. [8] Macdonald, R.L. and Barker, J.L., Specific antagonism of GABA-mediate postsynaptic inhibition in cultured mammalian spinal cord neurons: a common mode of convulsant action. Neurology, 28 (1978) 325-330.
9. [9] Mares, P., Pohl, M., Kubova, H. and Zelizko, M., Is the site of action of ethosuximide in the hindbrain?, Physiol. Res., 43 (1994) 51-56.
10. [10] Musolino, R., Gallitto, G., De Domenico, P., Bonazinga, M.M., Sturniolo, R., Labate, C. and Di Perri, R., Synergistic anticonvulsant effect of valproic acid and ethosuximide on pentylenetetrazole-induced epileptic phenomena in rats, J. Int. Med. Res., 19 (1991) 55-62.
11. [11] Olsen, R.W., The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs, Mol. Cell. Biochem., 39 (1981) 261-279.
12. [12] Pellegrini, A., Dossi, R.C., Dal Pos, P., Ermani, M., Zanotto, L. and Testa, G., Ethosuximide alters intrathalamic and thalamocortical synchronizing mechanisms: a possible explanation of its antiabsence effect, Brain Res., 497 (1989) 344-360.
13. [13] Psarropoulou, C., Matsokis, N., Angelatou, F. and Kostopoulos, G., Pentylenetetrazol-induced seizures decrease γ-aminobutyric acid-mediated recurrent inhibition and enhance adenosine-mediated depression, Epilepsia, 35 (1994) 12-19.
14. [14] Ramanjaneyulu, R. and Ticku, M., Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore, Eur. J. Pharmacol., 98 (1984) 337-345.
15. [15] Rock, D.M. and Taylor, C.P., Effects of diazepam, pentobarbital, phenytoin and pentylenetetrazol on hippocampal paired-pulse inhibition in vivo, Neurosci. Lett., 65 (1986) 265-270.
16. [16] Shouse, M.N., Stroh, P.J. and Vreeken, T., Temporal lobe and petit ma1 antiepileptics differentially affect ventral lateral thalamic and motor cortex excitability patterns, Brain Res., 473 (1988) 372-379.
17. [17] Squires, R.F., Saederup, E., Crawley, J.N., Skolnick, P. and Paul, S.M., Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain, Life Sci., 35 (1984) 1439-1444.
18. [18] Stringer, J.L., Pentylenetetrazol elicits epileptiform activity in the dentate gyrus of the urethane anesthetized rat by activation of the entorhinal cortex, Brain Res., 636 (1994) 221-226.
19. [19] Stringer, J.L., Valproic acid and ethosuximide slow the onset of maximal dentate activation in the rat hippocampus, Epilepsy Res., 19 (1994) 229-235.
20. [20] Stringer, J.L., Pentylenetetrazol causes polysynaptic responses to appear in the dentate gyrus, Neuroscience, 68 (1995) 407-413.
21. [21] Stringer, J.L. and Colbert, C.M., Analysis of field potentials evoked in CA1 by angular bundle stimulation in the rat, Brain Res., 641 (1994) 289-294.
22. [22] Stringer, J.L. and Lothman, E.W., Maximal dentate activation: a tool to screen compounds for activity against limbic seizures, Epilepsy Res., 5 (1990) 169-176.
23. [23] Stringer, J.L. and Lothman, E.W., Bilateral maximal dentate activation is critical for the appearance of an afterdischarge in the dentate gyrus, Neuroscience, 46 (1992) 309-314.
24. [24] Stringer, J.L. and Lothman, E.W., Reverberatory seizures discharges in hippocampal-parahippocampal circuits, Exp. Neurol., 116 (1992) 198-203.
25. [25] Stringer, J.L. and Sowell, K.L., Kainic acid, bicuculline, pentylenetetrazol and pilocarpine elicit maximal dentate activation in the anesthetized rat, Epilepsy Res., 18 (1994) 11-21.
26. [26] Stringer, J.L., Williamson, J.M. and Lothman, E.W., Induction of paroxysmal discharge in the dentate gyrus: frequency dependence and relationship to afterdischarge production, J. Neurophysiol., 62 (1989) 126-135.
27. [27] Wahle, H. and Frey, H.H., Development of tolerance to the anticonvulsant effect of valproate but not to ethosuximide in a rat model of absence epilepsy, Eur. J. Pharmacol., 181 (1990) 1-8.